Edwards Lifesciences Corporation

NYSE:EW Stock Report

Market Cap: US$43.7b

Edwards Lifesciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NYSE:EW Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Dec 24SellUS$128,223Daveen ChopraIndividual1,750US$73.27
06 Dec 24SellUS$42,716Wayne MarkowitzIndividual583US$73.27
20 Aug 24SellUS$87,438Daveen ChopraIndividual1,250US$69.95
23 Feb 24SellUS$267,911Kieran GallahueIndividual3,058US$87.61
21 Feb 24SellUS$104,103Daveen ChopraIndividual1,200US$86.75

Insider Trading Volume

Insider Buying: EW insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of EW?
Owner TypeNumber of SharesOwnership Percentage
State or Government710,8390.121%
Individual Insiders5,332,8110.904%
General Public82,377,35014%
Institutions501,379,00085%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 52.42% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.6%
The Vanguard Group, Inc.
62,594,542US$4.6b16.8%0.07%
9.25%
BlackRock, Inc.
54,585,166US$4.0b7.08%0.06%
5.35%
Wellington Management Group LLP
31,532,725US$2.3b86.3%0.35%
4.45%
State Street Global Advisors, Inc.
26,265,633US$1.9b0.99%0.07%
2.29%
Geode Capital Management, LLC
13,521,147US$1.0b2.15%0.07%
1.72%
Walter Scott & Partners Limited
10,129,267US$750.8m-3.58%1.57%
1.54%
Fisher Asset Management, LLC
9,078,311US$672.9m9.75%0.26%
1.45%
Norges Bank Investment Management
8,537,780US$632.8m0%0.05%
1.38%
BNY Asset Management
8,137,285US$603.1m-11.9%0.11%
1.32%
UBS Asset Management AG
7,795,944US$577.8m2.55%0.05%
1.32%
Ninety One UK Limited
7,756,264US$574.9m1,490%0.82%
1.28%
Brown Advisory Incorporated
7,566,995US$560.9m-54.2%0.64%
1.18%
AllianceBernstein L.P.
6,983,259US$517.6m-65.7%0.15%
1.02%
Deutsche Asset & Wealth Management
6,043,138US$447.9m72.7%0.12%
1%
JP Morgan Asset Management
5,889,357US$436.5m-4.5%0.05%
0.91%
Legal & General Investment Management Limited
5,355,811US$397.0m-0.63%0.07%
0.91%
Northern Trust Global Investments
5,339,382US$395.8m-6.59%0.06%
0.91%
Sands Capital Management, LLC
5,338,095US$395.7m-5.5%0.93%
0.76%
Wellcome Trust, Investment Division
4,500,000US$333.5m9.76%3.48%
0.69%
Michael Mussallem
4,042,863US$299.7m0%no data
0.63%
Marshall Wace LLP
3,733,777US$276.7m4,900%0.39%
0.63%
Jacobs Levy Equity Management Inc
3,693,663US$273.8m240%0.98%
0.62%
Charles Schwab Investment Management, Inc.
3,659,102US$271.2m1.47%0.04%
0.6%
Amundi Asset Management SAS
3,554,597US$263.5m-31.9%0.05%
0.6%
T. Rowe Price Group, Inc.
3,541,783US$262.5m-51.7%0.02%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 07:59
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Edwards Lifesciences Corporation is covered by 75 analysts. 33 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James Francis MainwaringAtlantic Equities LLP
David RescottBaird
Ishan MajumdarBaptista Research